These observations and the key role of IGF signaling in normal growth regulation have stimulated a considerable amount of interest in understanding the impact of IGF signaling on breast cancer risk, progression, prognosis, and the potential of this pathway as a therapeutic target. Here, IGF1 is linked to breast cancer.